Key indicators: single-crystal X-ray study; T = 298 K; mean (C-C) = 0.005 Å; R factor = 0.052; wR factor = 0.145; data-to-parameter ratio = 14.6.
In the title complex, [CuCl 2 (C 12 H 14 N 2 ) 2 ], the Cu 2+ cation is situated on an inversion centre and is coordinated by two N atoms from symmetry-related 1-mesityl-1H-imidazole ligands and by two chloride anions in a slightly distorted squareplanar geometry. In the organic ligand, the dihedral angle between the benzene ring of the mesityl moiety and the imidazole ring is 76.99 (18) . Weak intramolecular C-HÁ Á ÁCl hydrogen-bonding interactions consolidate the molecular conformation.
Related literature
For related structures, see: Awwadi (2013) ; Jia et al. (2005) . For the bioactivity of Cu complexes, see: Beaudoin et al. (2009) ; Deegana et al. (2007) ; Pettit & Ueda (1992) . For the photochemistry of Cu complexes, see: Kuang et al. (2002) ; Raptopoulou et al. (1998) ; Teyssot et al. (2007) .
Experimental
Crystal data [CuCl 2 (C 12 Table 1 Hydrogen-bond geometry (Å , ).
Data collection: APEX2 (Bruker, 2008 ); cell refinement: SAINT (Bruker, 2008) ; data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: SHELXTL (Sheldrick, 2008) ; software used to prepare material for publication: publCIF (Westrip, 2010) .
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: WM2773).
Comment
In recent years, phosphorescent Cu(II) complexes received attention due to their nontoxic properties (Deegana et al., 2007) , which make these complexes applicable in biological probing (Beaudoin et al., 2009; Deegana et al., 2007; Pettit & Ueda, 1992) , solar energy conversion, and organic light emitting devices (Kuang et al., 2002; Jia et al., 2005; Teyssot et al., 2007) . Our interest is focused on the design and synthesis of phosphorescent Cu(II) complexes with various ancillary ligands, and their applications in anti-cancer therapy (Awwadi, 2013; Raptopoulou et al., 1998) . We herein describe the synthesis and structural characterization of the title compound, [CuCl 2 (C 12 
Experimental
In a Schlenk flask, a solution of 1-mesityl-1H-imidazole (10 ml, 1M in CH 2 Cl 2 ) was added to a suspension of CuCl 2 (5 mmol) in 10 ml CH 2 Cl 2 at room temperature. The reaction was stirred in the absence of light for 6 h at this temperature.
The reaction mixture was then filtered in the dark and the volume of the solution reduced to 5.0 ml. Pentane was added to afford the product as an green solid in 40% yield. Single crystals suitable for X-ray diffraction were obtained by slow evaporation of a solution of the title compound in CH 2 Cl 2 at room temperature.
Refinement
C-bound H atoms were positioned geometrically and refined as riding atoms, with C-H = 0.93 (aromatic), 0.96 (CH 3 ) Å and with U iso (H)= 1.2 (1.5 for methyl) U eq (C).
Computing details
Data collection: APEX2 (Bruker, 2008 ); cell refinement: SAINT (Bruker, 2008) ; data reduction: SAINT (Bruker, 2008);  program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: SHELXTL (Sheldrick, 2008) ; software used to prepare material for publication:
publCIF (Westrip, 2010 
